Source – Pregabalin prescribing patterns in Australian general practice, 2012–2018: a cross-sectional study[/caption]
National Medicines Symposium 2024 speakers (L to R): Steve Waller, Professor Jennifer Martin, Professor Libby Roughead, Tegan Taylor[/caption]
This CPD activity is sponsored by Reckitt. All content is the true, accurate and independent opinion of the speakers and the views expressed are entirely their own.[/caption]
Poly (ADP-ribose) polymerase inhibitors for the treatment of ovarian cancer
Case scenario
Mrs Jones, aged 59, is a regular patient at your pharmacy. For the last few weeks she has come in almost daily to...
Pharmacists can have a big impact on men’s mental health
A recent report released by Beyond Blue has further revealed the state of men’s mental health in Australia. Pharmacists can help to intervene before...
Pharmacist advice app takes home Pharmacy Shark Tank prize
Patients would be able to seek pharmacist advice with a few taps on their smartphone, using a proposed app that has won the PSA19...
National Diabetes Week: now is the time to help people stay...
ADVERTORIAL BY GLUCERNA®
It can be challenging for those with impaired glucose tolerance or insulin resistance to maintain a healthy, low GI diet; especially considering...
First 100,000 Australians receive COVID-19 vaccines
More than 100,000 Australians have received their first COVID-19 vaccination, and the country now has 1.3 million doses on hand for the next rollout phases.
An innovative, effective OTC solution to scalp pruritus
Dermal Therapy’s Scalp Relief range is clinically proven to relieve scalp itch and irritation in minutes. It is steroid- and tar-free and targets multiple common causes of itchy scalp.
